Pharvaris has completed patient enrollment for its proof-of-concept CHAPTER-1 clinical trial that will evaluate the safety and effectiveness of…
Articles by Patricia Inácio, PhD
Enrollment for the Phase 2 portion of a clinical trial testing NTLA-2002, Intellia Therapeutics’ experimental gene-editing therapy for…
A 26-year-old woman developed a rare case of non-episodic angioedema associated with eosinophilia (NEAE) following her second dose of the…
The use of Dupixent (dupilumab), an approved treatment for skin and respiratory conditions linked to a specific type of…
Healthcare costs continuously dropped for people with hereditary angioedema (HAE) who were on long-term preventive treatment with Takhzyro…
Firazyr (icatibant injection) rapidly eased acute attack symptoms in two Japanese children with hereditary angioedema (HAE), according to…
An elderly woman developed angioedema about 20 days after being given ticagrelor, a medicine that prevents blood clots from…
Preventive treatment with Orladeyo (berotralstat) for up to two years led to prolonged periods of no swelling attacks in…
People with hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE) typically experience a significantly delayed diagnosis — even with a…
The prevalence of hereditary angioedema (HAE) in Asia-Pacific countries is lower than that reported for the disease in Western…